Abbott Laboratories (ABT) Aktie Kurs
Abbott Laboratories Kurs
De seneste 19 år voksede Abbott Laboratoriess omsætning med 3,6 % årligt og nåede 44,33 Mrd. USD. Indtjening pr. aktie er vokset med 6,6 % om året de seneste 19 år. For Abbott Laboratories er nettoavance på 14,7 % ned i forhold til 16,4 % for et par år siden. Ved dagens kurs bliver direkteafkastet cirka 2,22 %. Udlodningsandelen er omkring 63 % af indtjeningen. Udbyttet er vokset med 3,8 % om året de seneste 19 år. Konsensus 12-måneders kursmål for Abbott Laboratories er 121,00 USD, cirka over kursen med 13,9 %. Af 33 analytikere anbefaler 26 køb — den samlede vurdering er Køb.
Abbott Laboratories aktiekurs
Hent disse data via Eulerpool API
100.000 requests/md. gratis · intet kreditkort
Abbott Laboratories aktie og aktieanalyse
Hyppigt stillede spørgsmål om Abbott Laboratories-aktien
Abbott Laboratories is a renowned healthcare company with a strong business model focused on providing a diverse range of medical products, diagnostics, nutritional supplements, and pharmaceuticals. By combining technological advancements with innovative research, Abbott aims to enhance the quality of life for individuals worldwide. With a comprehensive portfolio spanning diverse healthcare sectors, including diagnostics, nutrition, diabetes care, medical devices, and branded generic pharmaceuticals, Abbott Laboratories strives to improve patient outcomes and deliver sustainable growth. Through its commitment to scientific excellence and dedication to meeting evolving healthcare needs, Abbott Laboratories has established itself as a trusted leader in the global healthcare industry.
Abbott Laboratories is primarily active in the healthcare industry.
The main competitors of Abbott Laboratories in the market are Johnson & Johnson, Pfizer, and Roche Holding AG.
Abbott Laboratories is a renowned American healthcare company, known for providing a diverse range of medical, pharmaceutical, and nutritional products. Founded in 1888 by Dr. Wallace C. Abbott, the company initially focused on producing pharmaceuticals, including the widely successful alkaloid-based pain reliever, Abbott's ABC Liniment. Over the years, Abbott Laboratories has expanded its portfolio, venturing into areas such as diagnostics, medical devices, and nutrition. The company's commitment to innovation is evident through breakthroughs like the development of the first HIV blood-screening test. Today, Abbott Laboratories continues to play a crucial role in improving health outcomes worldwide, with its cutting-edge technology and a focus on delivering quality healthcare solutions.
Abbott Laboratories has achieved several significant milestones throughout its history. One major milestone was the development and commercialization of the first-ever HIV blood screening test, which greatly contributed to safer transfusions and the prevention of the spread of HIV. Additionally, Abbott Laboratories introduced breakthrough medical devices, such as the FreeStyle® Libre system, a continuous glucose monitoring system for diabetes management. The company also played a crucial role in the fight against COVID-19 by developing rapid diagnostic tests for the virus. Furthermore, Abbott Laboratories has consistently been recognized for its commitment to innovation and sustainability, making it a leading healthcare company globally.
Abbott Laboratories is primarily present in multiple countries and regions worldwide. The company operates in more than 160 countries, including the United States, Canada, Europe, Asia-Pacific, Latin America, and the Middle East. With a strong global footprint, Abbott Laboratories has established itself as a leading healthcare company in various markets, delivering innovative medical products, diagnostics, nutritionals, and pharmaceuticals to improve people's health and well-being.
Abbott Laboratories is committed to its core values of putting patients first, serving customers with innovative solutions, and operating with integrity in all aspects of its business. The company's corporate philosophy centers around improving life through the development of groundbreaking technologies and products. Abbott Laboratories prides itself on its dedication to delivering reliable healthcare solutions, fostering collaboration with healthcare professionals, and investing in research and development to address unmet medical needs. With a focus on providing high-quality and accessible healthcare options, Abbott Laboratories strives to create positive impacts in communities worldwide through its diverse portfolio of medical devices, diagnostics, nutrition, and pharmaceutical products.
Analytikere sætter i øjeblikket et gennemsnitligt kursmål på 123,64 USD for Abbott Laboratories-aktien (median: 121,00 USD), svarende til +16,4 % i forhold til seneste kurs. Konsensus bygger på 33 analytikervurderinger.
33 analytikere vurderer i øjeblikket Abbott Laboratories-aktien: 26 anbefaler køb, 7 hold og 0 salg. For 2026 forventer analytikere, at Abbott Laboratories genererer omsætning på 49,99 Mrd. USD og indtjening pr. aktie på 5,52 USD.
Omregnet til den aktuelle valutakurs handles Abbott Laboratories-aktien til 94,87 EUR (106,20 USD).
Abbott Laboratories-aktien (ABT) er noteret på 9 børser, herunder: NYSE (ABT), London (0Q15.L), SIX (Zürich) (ABT.SW), XETRA (ABL.DE), Frankfurt (ABL.F), München (ABL.MU), Düsseldorf (ABL.DU), Hamburg (ABL.HM).
Abbott Laboratories is a global company specializing in the development, manufacturing, and marketing of health products and services. Its business model is divided into different divisions that focus on the needs of patients, doctors, and healthcare systems. The divisions of Abbott Laboratories include Diagnostics, Medical Devices, Nutrition, and Pharmaceutical. The company aims to continuously develop innovative technologies and products to improve healthcare, and it offers a wide range of services and support programs for patients. Abbott Laboratories has established a strong market position and global presence in over 160 countries since its establishment in 1888. It also pursues a successful acquisition strategy to expand its product portfolio, such as the acquisition of St. Jude Medical in 2017 to enhance its cardiovascular products and services. Overall, Abbott Laboratories aims to improve healthcare and meet the needs of patients, doctors, and healthcare systems through its comprehensive strategy focused on developing innovative products, expanding into new markets, and increasing efficiency.
forventet-omsætningen for Abbott Laboratories er 49,99 Mrd. USD. Dette tal er baseret på aktuelle finansielle data og afspejler virksomhedens forretningsydeevne.
forventet-overskuddet for Abbott Laboratories er 9,64 Mrd. USD. Nettooverskuddet afspejler virksomhedens rentabilitet efter fradrag af alle udgifter.
Pris-til-indtjening-forholdet (P/E) for Abbott Laboratories er i øjeblikket 19,24. P/E-forholdet sammenligner den nuværende aktiekurs med indtjeningen pr. aktie og hjælper investorer med at vurdere værdiansættelsen af Abbott Laboratories-aktien.
Pris-til-salgs-forholdet (P/S) for Abbott Laboratories er i øjeblikket 3,71. P/S-forholdet sammenligner markedskapitalisering med årlig omsætning og fungerer som en værdiansættelsesmetrik for Abbott Laboratories-aktien.
AlleAktien-kvalitetsscore for Abbott Laboratories er 6/10.
ISIN for Abbott Laboratories er US0028241000. ISIN (International Securities Identification Number) er en globalt unik identifikator for værdipapirer.
WKN for Abbott Laboratories er 850103. WKN (Wertpapierkennnummer) er et seks-cifret tysk identifikationsnummer for værdipapirer.
Tickeren for Abbott Laboratories er ABT. Tickersymbolet bruges til at handle Abbott Laboratories-aktier på børsen.
Abbott Laboratories aktie
Abbott Laboratories Peer Group
Abbott Laboratories Ticker
Abbott Laboratories FIGI
Alle fundamentale data om Abbott Laboratories i deep dive
Vores aktieanalyse af Abbott Laboratories-aktien indeholder vigtige finansielle nøgletal som omsætning, profit, P/E-ratioen, P/S-ratioen, EBIT samt informationer om udbytte. Desuden ser vi på aspekter som aktier, markedskapitalisering, gæld, egenkapital og forpligtelser hos Abbott Laboratories. Hvis du søger mere detaljerede oplysninger om disse emner, tilbyder vi på vores undersider omfattende analyser: